As part of safety testing for pharmaceuticals, sterility tests are conducted to check for microbial contamination. The compendial sterility test method requires a 14-day incubation period, which has increased the demand for faster testing methods, especially for cell-based medicines with short shelf lives. RiboNAT™ utilizes the NAT method (Nucleic Acid Amplification Test) to rapidly detect bacteria and fungi.



*Illustrations were created with BioRender.
Detection of 6 species described in pharmacopeias : Spiked 9 CFU/mL
Detectable at 9 CFU/mL
Spiked 9 CFU/mL with cell suspension sample
Test condition
*Detectable also in the below condition
Detectable at 9 CFU/mL with cell suspension sample
Higher sensitivity method




Detected 2 CFU/mL of strictly anaerobic bacteria and slow growth bacteria by 14 hours or longer incubation.
Extended incubation enhances sensitivity
RiboNAT™ includes treatment steps with a reagent for inactivating DNA from dead cells and DNase. This process helps reduce false positives caused by residual DNA in the sample.

False positive derived from residual DNA was reduced
| Detection method | One step reverse transcription real time PCR with fluorescence probe (RT-rt PCR) |
|---|---|
| Sensitivity | 100 RNA copies per reaction |
| Coverage* | Bacteria: 25,748 (95.7%) Fungi: 1,683 (92.3%) *In silico analysis, Accepting 3 mismatches, Data bank: Silva |
| Target | Bacteria: 23S Ribosomal RNA (Detection wavelength: 515-530nm) Fungi: 25/28S Ribosomal RNA (Detection wavelength: 675-690 nm) Internal Control: Artifact sequence (Detection wavelength: 560-580 nm) |



※RiboNAT™ RNA Isolation Kit 1, RNA Isolation Kit 2, Detection Kit are all required for the assay.